Literature DB >> 7862137

Basal promoter of the rat connexin 32 gene: identification and characterization of an essential element and its DNA-binding protein.

S Bai1, A Schoenfeld, A Pietrangelo, R D Burk.   

Abstract

The connexin 32 (Cx32) gene, a member of a multigene family, is expressed preferentially in the liver. The basal promoter complex of the rat Cx32 gene was previously localized to a 146-bp region (map positions [mp] -179 to -34) immediately upstream of the first exon. To investigate the biochemical factors contributing to the basal promoter activity, nuclear protein-DNA complexes within this region (mp -177 to -106) were investigated by using a DNA mobility shift assay. Three DNA-protein binding activities, termed Cx32-B1, Cx32-B2, and Cx32-B3, were identified with nuclear protein extracts from hepatoma cell lines, HuH7 and FAO-1. However, only Cx32-B2 binding activity was detected in nuclear protein extract from normal rat liver tissue. This activity was significantly more abundant in rat liver tissue than in hepatoma cell lines and tissues from various other organs. By using methylation interference footprinting, the Cx32-B2 complex was localized to the region between mp -152 and -127 and a DNA probe containing this region bound to a 60-kDa protein in rat liver nuclear extracts. Mutation of two nucleotides in the Cx32-B2 binding site abrogated the formation of the Cx32-B2 protein-DNA complex and significantly reduced the transcriptional activity of the Cx32 promoter. These results indicate that the Cx32-B2 complex is an essential component of the rat Cx32 basal promoter and is likely a major factor in the preferential expression of this gene in the liver.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7862137      PMCID: PMC230368          DOI: 10.1128/MCB.15.3.1439

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  34 in total

Review 1.  Transcription factors and liver-specific genes.

Authors:  V De Simone; R Cortese
Journal:  Biochim Biophys Acta       Date:  1992-09-24

Review 2.  Transcription by RNA polymerase II: initiator-directed formation of transcription-competent complexes.

Authors:  L Weis; D Reinberg
Journal:  FASEB J       Date:  1992-11       Impact factor: 5.191

3.  Distinctive gap junction channel types connect WB cells, a clonal cell line derived from rat liver.

Authors:  D C Spray; M Chanson; A P Moreno; R Dermietzel; P Meda
Journal:  Am J Physiol       Date:  1991-03

4.  The human connexin gene family of gap junction proteins: distinct chromosomal locations but similar structures.

Authors:  G I Fishman; R L Eddy; T B Shows; L Rosenthal; L A Leinwand
Journal:  Genomics       Date:  1991-05       Impact factor: 5.736

Review 5.  The gap junction family: structure, function and chemistry.

Authors:  R Dermietzel; T K Hwang; D S Spray
Journal:  Anat Embryol (Berl)       Date:  1990

6.  Transcriptional and posttranscriptional control of connexin mRNAs in periportal and pericentral rat hepatocytes.

Authors:  E Rosenberg; D C Spray; L M Reid
Journal:  Eur J Cell Biol       Date:  1992-10       Impact factor: 4.492

7.  Sp1 DNA binding efficiency is highly reduced in nuclear extracts from aged rat tissues.

Authors:  R Ammendola; M Mesuraca; T Russo; F Cimino
Journal:  J Biol Chem       Date:  1992-09-05       Impact factor: 5.157

8.  Reversible alteration in the expression of the gap junctional protein connexin 32 during tumor promotion in rat liver and its role during cell proliferation.

Authors:  M J Neveu; J R Hully; D L Paul; H C Pitot
Journal:  Cancer Commun       Date:  1990

9.  Sequence and tissue distribution of a second protein of hepatic gap junctions, Cx26, as deduced from its cDNA.

Authors:  J T Zhang; B J Nicholson
Journal:  J Cell Biol       Date:  1989-12       Impact factor: 10.539

10.  Differential changes in expression of gap junction proteins connexin 26 and 32 during hepatocarcinogenesis in rats.

Authors:  H Sakamoto; M Oyamada; K Enomoto; M Mori
Journal:  Jpn J Cancer Res       Date:  1992-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.